I have extensive experience as an expert witness specializing in giving testimony and consulting for a wide range of infectious diseases cases. I am committed to the highest professional standards offering rigorous and thoughtful records review and analysis.  I provide critical insight and evaluation to determine causation, uncover breaches in standards of care and to establish negligence resulting in significant measurable compensable  harm.

Core Infectious Disease Expertise

• Antimicrobial Stewardship

• Bacterial and Fungal Infections

• Multi-drug Resistant Pathogens

• COVID-19

• Endocarditis

• Osteomyelitis

• Pneumonia

• Sepsis

• Travel-Related Infections

• Waterborne Infections

Clinical Infections in the Community Across the Continuum of Care

• Cellulitis

• Necrotizing Fasciitis

• Orthopedic Infections

• Surgical Site Infections

• Medical Device Associated Infections

I provide expert consulting services to hospitals, ambulatory surgery centers, long term care facilities, dialysis centers, and other healthcare settings dedicated to protecting patients, staff, and visitors from preventable infections.

Robust infection prevention and control (IPC) programs are essential for reducing healthcare-associated infections (HAIs), ensuring regulatory compliance, and fostering a culture of safety. My tailored consulting services help institutions build, strengthen, and sustain evidence-based IPC programs that comply with regulatory rules and accreditation body standards, as well as evidence-based guidelines from recognized expert organizations such as the Society of Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC).

Key On-Site and/or Remote Services Include:

• Program Assessment and Gap Analysis: Comprehensive on-site or remote evaluation of existing IPC policies, practices, surveillance systems, and risk assessments to identify strengths and opportunities for improvement.

• Policy and Procedure Development: Creation or revision of evidence-based protocols for hand hygiene, isolation precautions, environmental cleaning, device-associated infection prevention, safe injection practices and antimicrobial-resistant organism management.

• Surveillance and Data Analysis: Design and implementation of HAI surveillance systems to inform NHSN reporting, facilitate outbreak detection, and generate actionable data to track trends and measure intervention impact.

• Outbreak Investigation and Management: Rapid response support for investigating and controlling outbreaks of multidrug-resistant organisms, Clostridioides difficile, viral respiratory pathogens, and other transmissible infections.

• Staff Education and Competency Training: Customized programs resulting in sustained behavior change for frontline staff, physicians, environmental services, and leadership with a focus on best practices, regulatory requirements and accredidation standards.

• Construction and Renovation Risk Assessments: Infection control risk assessments (ICRAs) for facility projects, including guidance on air handling, water management, and containment measures to prevent construction-related infections (e.g., Aspergillosis, Legionellosis).

• Water Management Programs: Development and oversight of Legionella and waterborne pathogen prevention plans in compliance with CMS and ASHRAE standards.

• Regulatory and Accredidation Survey Support: Mock tracers, corrective action planning, and on-site assistance to ensure continual readiness and full compliance.

• Tele-Infection Prevention Services: Remote consulting and virtual rounding options for rural or resource-limited facilities needing ongoing expert guidance.

By partnering with me, your organization can achieve lower HAI rates, improved patient outcomes, enhanced staff confidence, regulatory compliance, and substantial cost savings via harm avoidance.

I offer specialized consulting services to healthcare systems committed to combating antimicrobial resistance and improving patient outcomes.

Successful antimicrobial stewardship involves coordinated strategies to ensure the appropriate use of antimicrobials—selecting the right drug, dose, duration, and route—to maximize clinical effectiveness while minimizing toxicity, resistance, and unnecessary costs. My services are designed to help your institution implement or enhance a robust antimicrobial stewardship program (ASP) in alignment with regulatory mandates, accreidation standards and evidence-based guidelines.

Key Services Include:

• Program Development and Leadership: Guidance in establishing or refining ASPs, including appointing multidisciplinary teams, policy development, and integration with infection prevention efforts.

• Prospective Audit and Feedback: Daily review of antimicrobial prescriptions with personalized, evidence-based recommendations to prescribers for de-escalation, narrowing spectrum, or discontinuation.

• Pre-Authorization Support: Expertise in restricting high-risk or broad-spectrum agents, ensuring timely approvals while promoting judicious use.

• Education and Training: Tailored sessions for physicians, pharmacists, nurses, and staff on best practices, local resistance patterns (antibiograms), and guideline adherence.

• Data Analysis and Reporting: Tracking antimicrobial use, resistance trends, and outcomes to demonstrate program impact, cost savings, and compliance.

• Tele-Stewardship Options: Remote consulting for rural or resource-limited facilities, providing real-time expertise without on-site presence.

• Outbreak and Special Focus Support: Assistance with managing resistant organisms, C. difficile reduction, and stewardship in high-risk areas like ICUs or surgical services.

By partnering with me, your facility can improve patient safety, reduced antimicrobial resistance, lower infection rates and achieve cost savings.

I offer specialized consulting services to public health departments, hospitals, schools, workplaces, long-term care facilities, correctional institutions, and other organizations facing infectious disease challenges.

My expertise links clinical infectious diseases with population-level epidemiology, enabling comprehensive assessment, investigation, and control of infectious threats. I provide evidence-based guidance aligned with CDC, WHO, state health department protocols, and professional society recommendations to help clients prevent, detect, and respond effectively to infectious disease events.

Key Services Include:

• Outbreak Investigation and Management: Rapid deployment for on-site or remote support in investigating clusters and outbreaks of respiratory viruses, gastrointestinal illnesses, vaccine-preventable diseases, healthcare-associated infections, and emerging pathogens.

• Contact Tracing Program Design and Implementation: Development of scalable contact tracing systems, including integration of digital tools, case interview protocols, and monitoring/quarantine guidance in compliance with privacy regulations.

• Epidemiological Analysis and Surveillance: Design and enhancement of surveillance systems, data analysis (including epi curves, attack rates, and risk factor identification), and interpretation of public health data to inform decision-making.

• Risk Assessment and Modeling: Quantitative and qualitative risk assessments for infectious disease introduction or spread in specific settings, with scenario-based planning and basic transmission modeling when needed.

• Policy and Protocol Development: Creation of preemptive evidence-based guidelines for isolation, quarantine, testing strategies, vaccination programs, and return-to-work/school policies.

• Training and Capacity Building: Customized education for public health staff, healthcare workers, administrators, and community stakeholders on epidemiology principles, outbreak response, contact tracing techniques, and infection prevention.

• Expert Support for Emerging Threats: Guidance on novel or re-emerging pathogens, pandemic preparedness planning, and integration of lessons learned from events such as COVID-19, Mpox, or influenza pandemics.

• Legal and Public Communication Support: Assistance with clear, accurate risk communication to stakeholders, media, and the public, as well as epidemiologic support for litigation or regulatory inquiries related to outbreaks.